Seven Eight Capital’s CRISPR Therapeutics CRSP Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q2 | – | Sell |
-12,524
| Closed | -$854K | – | 736 |
|
2024
Q1 | $854K | Sell |
12,524
-17,032
| -58% | -$1.16M | 0.09% | 332 |
|
2023
Q4 | $1.85M | Buy |
29,556
+13,377
| +83% | +$837K | 0.21% | 139 |
|
2023
Q3 | $734K | Buy |
+16,179
| New | +$734K | 0.09% | 309 |
|
2022
Q4 | – | Sell |
-8,362
| Closed | -$546K | – | 450 |
|
2022
Q3 | $546K | Buy |
+8,362
| New | +$546K | 0.11% | 258 |
|